Shanghai Aimai Medical Technology

Shanghai Aimai Medical Technology, commonly known as iMed Medical, is a Chinese medical device company specializing in the development and manufacturing of high-end interventional medical consumables. Founded in 2016 and headquartered in Shanghai, the company focuses on interventional cardiology, peripheral vascular interventions, and neurovascular treatments. Its product portfolio includes PTCA and PTA balloon catheters, guide wires, and microcatheters, with a strong emphasis on innovative drug-coated balloon (DCB) technologies. iMed Medical aims to provide high-quality, cost-effective solutions for vascular diseases, leveraging its advanced R&D and manufacturing capabilities. The company has received significant backing from prominent investors like Sequoia China and Matrix Partners China.